6115Lec - [J] CVD PART 2

0.0(0)
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/113

encourage image

There's no tags or description

Looks like no tags are added yet.

114 Terms

1
New cards

Known as a cardiac glycoside

Digoxin

2
New cards

may be very toxic presenting several ADRs like ventricular tachycardia, AV block, and ventricular fibrillation.

Digoxin

3
New cards

Digoxin Toxicity is increased with?

thiazide diuretics, glucocorticoids, hypercalcemia (high calcium levels).

4
New cards

After discontinuance of digoxin ____must be provided to cardiac glycoside-induced toxicity

KCl

5
New cards

blocks Na+-K+-ATPase leading to increase intracellular Ca+2 that leads to increase heart contraction

Digoxin

6
New cards

the binding activity of digoxin is attributed to?

Ring A-B and C-D must be cis- fused

7
New cards

It is essential for the binding of digoxin

𝛼,β-unsaturated C17 lactone

8
New cards

essential for cardiotonic activity in digoxin

c14-OH

9
New cards

Enumerate Bipyridines

Inamrinone, Milrinone

10
New cards

It is a bipyridines that contains 2 pyridine rings

Milrinone

11
New cards

inhibits PDE to increase cAMP = increase contraction

Bipyridine

12
New cards

acts on the pacemaker current leading to lower HR and heart O2 demand

Ivabridine

13
New cards

used for heart failure not managed by beta-blocker monotherapy

Ivabridine

14
New cards

Class I are?

Na blockers

15
New cards

Class II are?

Beta Blockers

16
New cards

Class III are?

K+ blockers

17
New cards

Class IV are?

Ca+ blockers

18
New cards

Site of action of Class IA

atrial and ventricular tissue

19
New cards

Site of action of Class III

atrial and ventricular tissue

20
New cards

Site of action of Class IC

ventricular tissue

21
New cards

Site of action of Class IB

ventricular tissue

22
New cards

Site of action of Class II

sinoatrial (SA) /atrioventricular (AV) node

23
New cards

Site of action of Class IV

sinoatrial (SA) /atrioventricular (AV) node

24
New cards

Class IA Drugs

Disopyramide, Procainamide, Quinidine, Moricizine

25
New cards

Class IB Drugs

Lidocaine, Mexiletine, Phenytoin (non-FDA approved)

26
New cards

Class IC Drugs

Flecainide, Propafenone

27
New cards

Class II Drugs

Propranolol, Sotalol, Esmolol (cardioselective)

28
New cards

Class III Drugs

Amiodarone, Dronedarone, Dofetilide, Ibutilide, Sotalol (II and III)

29
New cards

Class IV Drugs

Diltiazem, Verapamil

30
New cards

increases refractory period leading to decrease conduction velocity and spontaneous diastolic depolarization of pacemaker cells.

Class IA Drugs

31
New cards

weakly blocks Na+ channel leading to shortened repolarization, decreasing duration of action potential.

Class IB Drugs

32
New cards

blocks Na+ channel to slow down conduction of electrical impulse.

Class IC Drugs

33
New cards

block sympathetic cardiac stimulation resulting to decreases Ca+2 influx and decreasing force and rate of cardiac contraction

Class II Drugs

34
New cards

blocks K+ channel leading to prolonged action potential.

Class III Drugs

35
New cards

blocks slow inward current carried by Ca+2, decreasing AV conduction and spontaneous depolarization, blocking conduction of premature impulses

Class IV Drugs

36
New cards

natural Class IC

PROPAFENONE

37
New cards

structural similar to Propranolol, thus exhibits beta-blocker activity as well

PROPAFENONE

38
New cards

Class III DOC for Tachyarrhythmias, contains iodine, may pose iodine- related problems

AMIODARONE

39
New cards

amiodarone analog w/o iodine

DRONEDARONE

40
New cards

Enumerate Bile acid Sequestrants

cholestyramine, colestipol, colesevelam

41
New cards

binds and excretes bile acid, stimulating the body to use cholesterol to produce bile leading to lower serum cholesterol and LDL.

Bile acid Sequestrants

42
New cards

essentail for binding bile acid

Cationic Amines

43
New cards

For hypercholesterolemia

Bile acid Sequestrants

44
New cards

selectively blocks cholesterol-active transporting protein leading to reduced intestinal cholesterol absorption from dietary sources.

Ezetimibe

45
New cards

It is used for hypercholesterolemia (best in combination with simvastatin)

Ezetimibe

46
New cards

This is esential for activity in Ezetimibe

1,4-diaryl-β-lactam

47
New cards

This results in the Longer DOA in Ezetimibe

p-fluoro substitutions prevents aromatic hydroxylation

48
New cards

________________ localizes the drug in the small intestine

Phenolic and alcoholic hydroxyls

49
New cards

inhibits DAGAT2, preventing acylation of diacylglycerides to TAGs.

Niacin / Nicotinic Acid

50
New cards

prevent receptor-mediated uptake of HDL

Niacin / Nicotinic Acid

51
New cards

the prevention of receptor-mediated uptake of HDL results in

increasing HDL levels

52
New cards

Any modification of niacin structure results to

Inactivity

53
New cards

These are essential for the acivity of Niacins

anionic state and -COOH

54
New cards

Amide forms in Niacins are?

Inactive

55
New cards

It is used for hypertriglyceridemia

Niacin / Nicotinic Acid

56
New cards

Enumerate Fibrates / Fibric Acids

Gemfibrozil, Fenofibrate

57
New cards

Fibrates / Fibric Acids are derivatives of

phenoxyisobutyrate

58
New cards

activates PPAR𝛂 → increases lipoprotein lipase expression

Fibrates / Fibric Acids

59
New cards

reduces TAGs and VLDL levels, increases HDL levels.

Fibrates / Fibric Acids

60
New cards

They are essential for activity in Fibrates

phenoxy and isobutyric acid moiety

61
New cards

Competitively inhibits HMGR leading to inhibition of de novo cholesterol biosynthesis resulting to lower LDL.

HMG-CoA Reductase Inhibitors

62
New cards

Statins must be

anionic state and -COOH

63
New cards

In HMG-CoA Reductase Inhibitors this is essntial for activity

dihydoxyhepatan(en)oic acid

64
New cards

In HMG-CoA Reductase Inhibitors C3 -OH must be in __configuration

R

65
New cards

In HMG-CoA Reductase Inhibitors C5-OH can be?

R or S

66
New cards

Statins with polar functional group increase affinity and potency for

Rosuvastatin and Atorvastatin

67
New cards

Statins with polar functional group deccrease affinity and potency for

Pravastatin

68
New cards

Natural HMGR inhibitors contain?

Decalin with lactone

69
New cards

Synthetic HMGR inhibitors contain?

,5-DIHYDROXY-COOH and p-FLUOROPHENYL

70
New cards

Enumerate Natural HMGR inhibitors

Lovastatin, simvastatin

71
New cards

isolated from Aspergillus terreus

Lovastatin

72
New cards

6 membered ring

Rosuvastatin

73
New cards

5 membered ring

Atorvastatin

74
New cards

Enumerate Orphan Drugs

Lomitapide and Mipomersen

75
New cards

used for genetic mutation in HoFH (lack of LDL receptors)

Lomitapide and Mipomersen

76
New cards

inhibitor TAG incorporation in VLDL and LDL

Lomitapide and Mipomersen

77
New cards

people with liver disease and with CYP 3A4 inhibitors, serious risk of hepatotoxicity.

Lomitapide and Mipomersen

78
New cards

cause vasoconstriction to prevent blood loss and pathogen spread

Thromboxanes

79
New cards

Inhibition of ADP binding on P2Y12 receptor

Clopidogrel, Ticlopidine, Prasugrel

80
New cards

Inhibition of thromboxane A2 (TXA2)

Aspirin

81
New cards

Binds to Glycoprotein IIb/IIIa (GP IIb/GP IIIa)

Abcixima, Eptifibatide, Tirofiban

82
New cards

has anti-inflammatory activity and affects prostaglandin synthesis

Aspirin

83
New cards

irreversibly inhibits COX-1 near active site → inhibits TXA2 synthesis → reduced lately activation

Aspirin

84
New cards

inhibits PDE leading to increased cAMP = reduces platelet activity

PDE inhibitors

85
New cards

Dipyridamole, Cilostazol

PDE inhibitors

86
New cards

Increased camp will result to?

Reduced platelet activity

87
New cards

binds to P2Y purinergic receptors leading to decreased ADP binding

(thienopyridines

88
New cards

decreased ADP binding will result in

Decreased platelet aggregatiojn

89
New cards

P2Y / ADP Inhibitors

Clopidogrel, Ticlopidine, Prasugrelm, Ticagrelor

90
New cards

Inhibition of Factor IIa (thrombin)

Heparin, Enoxaparin, Fondapirinux

91
New cards

Inhibition of Factor Xa

Apixaban, Rivaroxaban, Edoxaban

92
New cards

Inhibition of Vit. K-dependent Factors

Warfarin

93
New cards

sulfate glycosaminoglycan.

Heparin

94
New cards

requires monitoring of use.

Unfractionated heparin (UFH)

95
New cards

more predictable w/ less monitoring.

Low Molecular Weight heparin (LMWH) and Fondaparinux

96
New cards

ADR of Heparin

Bleeding

97
New cards

Bleeding due to heparin may be relieved by

Protamine

98
New cards

from Hirudo medicinalis, medical leech

Direct Thrombin Inhibitors

99
New cards

Enumerate Direct Thrombin Inhibitors from leech

Hirudin, Lepirudin, Desirudin, Bivalirudin

100
New cards

Enumerate Direct Thrombin Inhibitors from lsmall mlecule inhibitors

Argatroban, Dabigatran